Universal Health Is Maintained at Overweight by Wells Fargo
Universal Health Servs Analyst Ratings
BofA Securities Downgrades Universal Health Services(UHS.US) to Hold Rating, Announces Target Price $223
Wells Fargo Maintains Universal Health Services(UHS.US) With Buy Rating, Raises Target Price to $285
BofA Securities Downgrades Universal Health Services(UHS.US) to Hold Rating, Announces Target Price $223
Wells Fargo Remains a Buy on Universal Health (UHS)
Goldman Sachs Adjusts Price Target on Universal Health Services to $228 From $229
Leerink Partners Maintains Universal Health Services(UHS.US) With Buy Rating, Announces Target Price $270
Deutsche Bank Maintains Universal Health Services(UHS.US) With Buy Rating, Raises Target Price to $240
Universal Health Is Maintained at Buy by TD Cowen
Universal Health Price Target Cut to $275.00/Share From $283.00 by TD Cowen
TD Cowen Maintains Universal Health Services(UHS.US) With Buy Rating, Maintains Target Price $275
RBC Capital Maintains Universal Health Services(UHS.US) With Hold Rating, Raises Target Price to $211
RBC Cuts Price Target on Universal Health Services to $211 From $222, Keeps Sector Perform Rating
TD Cowen Maintains Universal Health Services(UHS.US) With Buy Rating, Cuts Target Price to $275
Universal Health Is Maintained at Overweight by Barclays
Universal Health Price Target Maintained With a $219.00/Share by Cantor Fitzgerald
Universal Health Servs Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Universal Health Servs, Maintains $219 Price Target
Leerink Partners Maintains Universal Health Services(UHS.US) With Buy Rating